Observational studyJournal of neurology2024
Alemtuzumab induces severe orbitopathy in relapsing-remitting multiple sclerosis.
Pablo Rodríguez de Vera Gómez et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this paperpooled itcites it